162 related articles for article (PubMed ID: 22926004)
1. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.
Bogen DL; Perel JM; Helsel JC; Hanusa BH; Romkes M; Nukui T; Friedman CR; Wisner KL
Psychopharmacology (Berl); 2013 Jan; 225(2):441-51. PubMed ID: 22926004
[TBL] [Abstract][Full Text] [Related]
2. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
[TBL] [Abstract][Full Text] [Related]
3. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
[TBL] [Abstract][Full Text] [Related]
4. Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women.
Bogen DL; Hanusa BH; Perel JM; Sherman F; Mendelson MA; Wisner KL
J Clin Psychiatry; 2017; 78(8):e1013-e1019. PubMed ID: 28994902
[TBL] [Abstract][Full Text] [Related]
5. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
[TBL] [Abstract][Full Text] [Related]
6. Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder.
Wilder CM; Hosta D; Winhusen T
J Subst Abuse Treat; 2017 Sep; 80():33-36. PubMed ID: 28755770
[TBL] [Abstract][Full Text] [Related]
7. Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women.
Cleary BJ; Reynolds K; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
Addiction; 2013 Apr; 108(4):762-70. PubMed ID: 23216809
[TBL] [Abstract][Full Text] [Related]
8. Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.
Bogen DL; Perel JM; Helsel JC; Hanusa BH; Thompson M; Wisner KL
Breastfeed Med; 2011 Dec; 6(6):377-84. PubMed ID: 21348770
[TBL] [Abstract][Full Text] [Related]
9. CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.
Wang SC; Ho IK; Tsou HH; Tian JN; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Chen CY; Liu SC; Wu HY; Chan HW; Tsai MH; Lin PS; Liu YL
J Clin Psychopharmacol; 2011 Aug; 31(4):463-9. PubMed ID: 21694616
[TBL] [Abstract][Full Text] [Related]
10. Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
Victorri-Vigneau C; Verstuyft C; Bouquié R; Laforgue EJ; Hardouin JB; Leboucher J; Le Geay B; Dano C; Challet-Bouju G; Grall-Bronnec M
Br J Clin Pharmacol; 2019 Jul; 85(7):1538-1543. PubMed ID: 30907440
[TBL] [Abstract][Full Text] [Related]
11. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G
Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731
[TBL] [Abstract][Full Text] [Related]
12. Methadone N-demethylation by the common CYP2B6 allelic variant CYP2B6.6.
Gadel S; Crafford A; Regina K; Kharasch ED
Drug Metab Dispos; 2013 Apr; 41(4):709-13. PubMed ID: 23298862
[TBL] [Abstract][Full Text] [Related]
13. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
[TBL] [Abstract][Full Text] [Related]
14. Postpartum changes in methadone maintenance dose.
Pace CA; Kaminetzky LB; Winter M; Cheng DM; Saia K; Samet JH; Walley AY
J Subst Abuse Treat; 2014 Sep; 47(3):229-32. PubMed ID: 24953167
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
[TBL] [Abstract][Full Text] [Related]
16. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
Dobrinas M; Crettol S; Oneda B; Lahyani R; Rotger M; Choong E; Lubomirov R; Csajka C; Eap CB
Pharmacogenet Genomics; 2013 Feb; 23(2):84-93. PubMed ID: 23249875
[TBL] [Abstract][Full Text] [Related]
17. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
Chang Y; Fang WB; Lin SN; Moody DE
Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
Gerber JG; Rhodes RJ; Gal J
Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
[TBL] [Abstract][Full Text] [Related]
19. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
[TBL] [Abstract][Full Text] [Related]
20. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
Clin Chem; 2011 Mar; 57(3):449-58. PubMed ID: 21245372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
